The US Food and Drug Administration is weighing whether to issue an order to force Philips Respironics to draw up a plan to repair, replace or issue refunds to customers who bought one of the company’s recalled breathing machines.
The order would be carried out under Sec. 518(b) of the Food, Drug, and Cosmetic Act, which gives the...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?